With the conservation of the relevant amino acid positions in hand, we next carried out biochemical and biophysical analysis of the Casq2 mutants in order to gain insight into the contribution of these mutations to the development of CPVT. This evidence concerns the gene CASQ2 and catecholaminergic polymorphic ventricular tachycardia.